414 related articles for article (PubMed ID: 8425944)
1. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
[TBL] [Abstract][Full Text] [Related]
2. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
[TBL] [Abstract][Full Text] [Related]
3. Identification and localization of 5-HT1P receptors in the guinea pig pancreas.
Kirchgessner AL; Liu MT; Tamir H; Gershon MD
Am J Physiol; 1992 Mar; 262(3 Pt 1):G553-66. PubMed ID: 1550243
[TBL] [Abstract][Full Text] [Related]
4. 5-HT transporter sites and 5-HT1A and 5-HT3 receptors in Fawn-Hooded rats: a quantitative autoradiography study.
Chen F; Lawrence AJ
Alcohol Clin Exp Res; 2000 Jul; 24(7):1093-102. PubMed ID: 10924015
[TBL] [Abstract][Full Text] [Related]
5. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
7. [(3)H]-8-OH-DPAT binding in the rat brain raphe area: involvement of 5-HT(1A) and non-5-HT(1A) receptors.
Assié MB; Koek W
Br J Pharmacol; 2000 Jul; 130(6):1348-52. PubMed ID: 10903975
[TBL] [Abstract][Full Text] [Related]
8. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
9. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
[TBL] [Abstract][Full Text] [Related]
10. Development of neural receptors for serotonin in the murine bowel.
Branchek TA; Gershon MD
J Comp Neurol; 1987 Apr; 258(4):597-610. PubMed ID: 3584550
[TBL] [Abstract][Full Text] [Related]
11. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
Le Saux M; Di Paolo T
J Psychiatry Neurosci; 2005 Mar; 30(2):110-7. PubMed ID: 15798786
[TBL] [Abstract][Full Text] [Related]
12. Combined in situ hybridisation, northern blot analysis, and receptor binding studies in clones expressing different levels of the human 5-HT1A receptor.
Konings PN; Shahid M; van Alebeek C; Makkink WK; Stam NJ; Ruigt GS; Vanderheyden PM
J Recept Signal Transduct Res; 1995; 15(1-4):443-55. PubMed ID: 8903956
[TBL] [Abstract][Full Text] [Related]
13. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
14. Non 5-HT1A/5-HT1C [3H]5-HT binding sites in the hamster, opossum, and rabbit brain show similar regional distribution but different sensitivity to beta-adrenoceptor antagonists.
Waeber C; Palacios JM
Synapse; 1992 Dec; 12(4):261-70. PubMed ID: 1361246
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
[TBL] [Abstract][Full Text] [Related]
16. Characterization and localization of a peripheral neural 5-hydroxytryptamine receptor subtype (5-HT1P) with a selective agonist, 3H-5-hydroxyindalpine.
Branchek TA; Mawe GM; Gershon MD
J Neurosci; 1988 Jul; 8(7):2582-95. PubMed ID: 3249244
[TBL] [Abstract][Full Text] [Related]
17. Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography.
Fanelli RJ; McMonagle-Strucko K
Synapse; 1992 Sep; 12(1):75-81. PubMed ID: 1357765
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of [3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit.
Chidlow G; De Santis LM; Sharif NA; Osborne NN
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2238-45. PubMed ID: 7558717
[TBL] [Abstract][Full Text] [Related]
20. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]